Biohaven Ltd (NY: BHVN )
13.75 -0.19 (-1.36%) Official Closing Price Updated: 7:00 PM EDT, Mar 21, 2023 Add to My Watchlist
All News about Biohaven Ltd
12 Health Care Stocks Moving In Monday's After-Market Session
February 13, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
January 04, 2023
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
December 02, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of...
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
October 12, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
12 Health Care Stocks Moving In Monday's Intraday Session
October 10, 2022
Biohaven Ltd. Surges 7.6%: Is This An Indication Of Further Gains?
October 07, 2022
Biohaven Ltd. shares ended the last trading session 7.6% higher at $13.18. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares...
Via Talk Markets
Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For...
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
October 03, 2022
From Pfizer Inc.
Via Business Wire
Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months
September 29, 2022
Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following